Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20161
20171
20223
20232
20245
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting9
Active, not recruiting3
Terminated3
Not yet recruiting2
Enrolling by invitation1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.6
Haisco Pharmaceutical Group Co., Ltd.5
Joincare Pharmaceutical Group Industry Co., Ltd3
AstraZeneca2
Air Force Military Medical University, China1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Eli Lilly and Company1
Ganzhou Hemay Pharmaceutical Co., Ltd1
Guangdong Hengrui Pharmaceutical Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive30
Bronchitis, Chronic2
Emphysema2
Bronchiectasis1
Lung Diseases1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.